| The NSW Office for Health and Medical Research (OHMR) has provided this guidance for sponsors, sites and researchers, for conducting clinical trials affected by the COVID-19 situation. The guidance is designed to assist operational requirements in NSW and will be continually updated as the situation evolves. Even after publication, NSW OHMR is keen to continue to receive feedback on this guidance to ensure it covers appropriate areas of need. From this, a set of FAQs will be developed which will be progressively expanded. |
